Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2013
10/30/2013EP2656843A1 Esters of bendamustine and related compounds, and medical use thereof
10/30/2013EP2656842A2 Androgen receptor modulator for the treatment of prostate cancer and androgen receptor-associated diseases
10/30/2013EP2656841A1 Androgen receptor modulator for the treatment of prostate cancer and androgen receptor-associated diseases
10/30/2013EP2656840A1 Method for producing polymerized coordination compounds of platinum complex
10/30/2013EP2656839A1 Use of Cyclohexanehexol Derivatives in the Treatment of Ocular Diseases
10/30/2013EP2656835A1 Long-lasting controlled-release liposome composition and method for producing same
10/30/2013EP2656834A1 Carotenoid oil suspension with high bioavailability and preparation method thereof
10/30/2013EP2656833A1 Crosslinked Hyaluronic Acid Compositions For Tissue Augmentation
10/30/2013EP2656734A2 Stabilized, antimicrobially effective composition with a content of bispyridinium alkane
10/30/2013EP2655706A2 Methods of screening compounds that are cytotoxic to tumor cells and methods of treating tumor cells using such compound
10/30/2013EP2655394A1 Novel 19-nor-steroids and their use for treating progesterone-dependent conditions
10/30/2013EP2655392A1 Cyclic nucleotide analogs
10/30/2013EP2655390A2 Purified cardiogenin isomer and related methods
10/30/2013EP2655388A1 Selective glycosidase inhibitors and uses thereof
10/30/2013EP2655385A1 Novel platinum-carbene complexes and use thereof as medicaments
10/30/2013EP2655379A1 Derivatives of englerin for the treatment of cancer
10/30/2013EP2655378A1 Compounds and their use as bace inhibitors
10/30/2013EP2655377A1 2-amino-4-arylthiazole compounds as trpa1 antagonists
10/30/2013EP2655376A1 5,6-DIHYDRO-IMIDAZO[1,2-a]PYRAZIN-8-YLAMINE DERIVATIVES USEFUL AS INHIBITORS OF BETA-SECRETASE (BACE)
10/30/2013EP2655375A1 Pyrimidinone derivatives, preparation thereof and pharmaceutical use thereof
10/30/2013EP2655374A1 N-(1-(substituted-phenyl)ethyl)-9h-purin-6-amines as pi3k inhibitors
10/30/2013EP2655372A2 Pyrroloquinolinyl-pyrrolidine-2,5-dione compositions and methods for preparing and using same
10/30/2013EP2655371A1 Pyrazolopiperidine compounds as ccr1 receptor antagonists
10/30/2013EP2655370A1 Compositions and methods for modulating fxr
10/30/2013EP2655369A1 Compositions and methods for modulating farnesoid x receptors
10/30/2013EP2655368A1 Compositions and methods for modulating farnesoid x receptors
10/30/2013EP2655367A1 N-substituted azetidine derivatives
10/30/2013EP2655365A1 2-carboxamide-4-piperazinyl-benzofuran derivative
10/30/2013EP2655364A1 A process for the preparation of lapatinib and its ditosylate salt
10/30/2013EP2655362A1 Hepatitis c inhibitors and uses thereof
10/30/2013EP2655359A1 Conjugated 3-(indolyl)- and 3-(azaindolyl)-4-arylmaleimide compounds and their use in tumor treatment
10/30/2013EP2655358A1 Oxindolopyrimidine as igf1r receptor inhibitors
10/30/2013EP2655357A1 Indazolyl triazole derivatives as irak inhibitors
10/30/2013EP2655356A1 Faah inhibitors
10/30/2013EP2655355A1 New triazolylphenyl sulfonamides as serine/threonine kinase inhibitors
10/30/2013EP2655350A1 Bicyclic pkm2 activators
10/30/2013EP2655348A1 Synthesis of intermediates for preparing anacetrapib and derivatives thereof
10/30/2013EP2655345A1 Aryl triazole compounds with antitumoural activity
10/30/2013EP2655344A1 Novel phenazine derivatives and their use
10/30/2013EP2655343A1 Polymorphs of 3-chloro-4[(2r)-2
10/30/2013EP2655340A1 Bi-heteroaryl compounds as vps34 inhibitors
10/30/2013EP2655336A1 Cancer targeting using carbonic anhydrase isoform ix inhibitors
10/30/2013EP2655335A1 Novel imidazole-2-benzamide compounds useful for the treatment of osteoarthritis
10/30/2013EP2655332A1 Novel morphinans useful as analgesics
10/30/2013EP2655331A1 Glucagon receptor modulators
10/30/2013EP2655330A1 Substituted pyridines as sodium channel blockers
10/30/2013EP2655329A1 Novel multicomponent crystals made of ([2-amino-6-(4-fluoro-benzylamino)-pyridin-3-yl]-carbamic acid ethyl ester and an arylpropionic acid
10/30/2013EP2655328A1 Novel multicomponent crystals made of ([2-amino-6-(4-fluoro-benzylamino)- pyridin-3-yl]-carbamic acid ethyl ester and 2-[2-[(2,6-dichlorphenyl)-amino]-phenyl]-acetic acid
10/30/2013EP2655326A1 4- (hetero) aryl - ethynyl - octahydro - indole - 1 - carboxylic acid esters
10/30/2013EP2655323A1 Ingenol-3-acylates iii and ingenol-3-carbamates
10/30/2013EP2655312A1 3-acyl-ingenols ii
10/30/2013EP2655311A1 Ingenol-3-acylates i
10/30/2013EP2655309A1 Methods and compositions for treating lung cancer
10/30/2013EP2655304A1 Halogenated biphenols as antibacterial agents
10/30/2013EP2655295A1 Radioiodinated guanidines
10/30/2013EP2654900A1 Combinations for treating hcv
10/30/2013EP2654899A1 Methods for treating neurological conditions and compositions and materials therefor
10/30/2013EP2654791A1 Methods for treating systemic lupus erythematosus using hiv protease inhibitors
10/30/2013EP2654777A2 Methods and compositions suitable for managing blood glucose in animals
10/30/2013EP2654774A2 Methods for treating metabolic disorders and obesity with gip and glp-1 receptor-active glucagon-based peptides
10/30/2013EP2654763A1 Use of marihuana and compounds therein for treating obesity
10/30/2013EP2654759A1 Long wearing powder-based cosmetic compositions
10/30/2013EP2654758A1 A composition comprising at least two compounds which induces indolamine 2,3-dioxygenase (ido), for the treatment of an autoimmune disorder or suffering from immune rejection of organs
10/30/2013EP2654757A1 The use of spinosyns and spinosyn compositions as local anesthetics and as antiarrhythmic agents
10/30/2013EP2654756A1 Compound having antibacterial activity
10/30/2013EP2654755A1 Combination
10/30/2013EP2654754A2 Combination
10/30/2013EP2654753A1 Sanglifehrin derivatives and methods for their production
10/30/2013EP2654752A1 Diarylpyridazinone derivatives, preparation thereof, and use thereof for the treatment of humans
10/30/2013EP2654751A1 Phosphorus-substituted quinoxaline-type piperidine compounds and uses thereof
10/30/2013EP2654750A1 Novel fused pyridine compounds as casein kinase inhibitors
10/30/2013EP2654749A2 Methods for treating copd
10/30/2013EP2654748A1 Indazole derivatives useful as erk inhibitors
10/30/2013EP2654747A1 Formulations of antiparasitic agents for topical administration to swine
10/30/2013EP2654746A1 Antibacterial or anti-acne formulations containing usnic acid or an usnate and a metal salt
10/30/2013EP2654745A1 Composition for the treatment of skin conditions
10/30/2013EP2654744A1 Methods and compositions for preventing and treating osteoarthritis
10/30/2013EP2654743A1 Combination comprising d-apartic acid and l-arginine or salts thereof for the improvement of cognitive activities and memory in dementia such as dementia senile and alzheimer's disease
10/30/2013EP2654742A2 Methods of improving cognitive function
10/30/2013EP2654741A1 Modulators and methods for the treatment of rosacea
10/30/2013EP2654740A1 Antibacterial and antifungal substances biphenylyl compounds
10/30/2013EP2654739A2 Percutaneous absorption preparation containing rivastigmine
10/30/2013EP2654738A1 Chewing gum composition comprising cross-linked polyacrylic acid
10/30/2013EP2654737A1 Novel preparation of an enteric release system
10/30/2013EP2654736A2 Novel pharmaceutical composition
10/30/2013EP2654734A2 Encased tamper resistant controlled release dosage forms
10/30/2013EP2654733A2 Tamper resistant solid oral dosage forms
10/30/2013EP2654730A2 High drug load pharmaceutical formulations comprising dronedarone and its pharmaceutically acceptable salts
10/30/2013EP2654729A2 Homogenous pharmaceutical oral dosage forms comprising lercanidipine and enalapril or their pharmaceutically acceptable salts
10/30/2013EP2654727A1 Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans
10/30/2013EP2654726A1 Solid dispersion formulations and methods of use thereof
10/30/2013EP2654722A1 Pharmaceutical composites of poorly water soluble drugs and polymers
10/30/2013EP2654721A2 Pharmaceutical compositions of pyridinium and quinolinium derivatives
10/30/2013EP2654720A1 Process for the preparation of a pharmaceutical composition comprising a low soluble pharmaceutically active ingredient
10/30/2013EP2654719A1 Aqueous solution of ambroxol
10/30/2013EP2654718A1 Dermatological foams obtained from a gel or suspension containing benzoyl peroxide
10/30/2013EP2654717A1 Dermatological foams obtained from a gel or suspension containing adapalene
10/30/2013EP2654716A1 Dermatological foams obtained from a gel or suspension containing a combination of adapalene and benzoyl peroxide
10/30/2013EP2654700A1 Otic composition for companion animals
10/30/2013EP2654686A2 Cosmetic preparations having a calming effect
1 ... 510 511 512 513 514 515 516 517 518 519 520 521 522 523 524 525 526 527 528 529 530 ... 7860